Use of Ovostim-CT in the prevention of hepatosis and retention of placenta in cows after calving

High milk productivity of cows after calving is the cause of liver damage in the form of hepatosis and premature retirement of animals. In such cases, a pathological examination simultaneously reveals violations in the form of protein and fatty degenerations with the subsequent destruction of cells,...

Full description

Saved in:
Bibliographic Details
Published in:E3S web of conferences 2021, Vol.282, p.3014
Main Author: Burkov, P.V.
Format: Article
Language:English
Subjects:
Albumins
Blood
Complications
Cow's milk
Cytotoxicity
Dairy cattle
Damage prevention
Dosage
Liver
Milk
Muscles
Placenta
Postpartum
Prevention
Proteins
Retention
Retirement
Spleen
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:High milk productivity of cows after calving is the cause of liver damage in the form of hepatosis and premature retirement of animals. In such cases, a pathological examination simultaneously reveals violations in the form of protein and fatty degenerations with the subsequent destruction of cells, as well as disturbed circulation in the liver. Also, hepatoses can cause such postpartum complications in cows as retention of placenta. For the prevention of hepatosis, the drug “Ovostim-ct” is proposed, which contains cytotoxic sera against the tissues of the liver, ovary, spleen and muscle. In order to prevent liver damage and postpartum retention of placenta, the drug is used 1-1.5 months before calving at a dose of 1 ml per 100 kg of live weight subcutaneously or intramuscularly. The use of the hepatoprotector allowed to reduce the number of cases of hepatosis and retention of placenta in cows after calving. Also, “Ovostim-ct” had a favorable effect on the biochemical parameters of the blood serum of cows: there was an increase in the concentration of total protein by 6.7%, albumin - by 15.6% and glucose - by 45.8% in the blood.
ISSN:2267-1242
2555-0403
2267-1242
DOI:10.1051/e3sconf/202128203014